Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
6,368.85
(
-1.67%
)
US TECH 100
22,459.60
(
-2.14%
)
Dow Jones
45,166.64
(
-1.73%
)
Brent Oil
106.89
(
6.18%
)
Bitcoin
66,060.27
(
-3.96%
)
News Focus
News Focus
Post# of 10861
Next 10
Public Reply Private Reply New Post
Keep Last Read
Replies (2) Keep Next 10 Report Keyboard Shortcuts
Replies (2) Next 10 Prev Next

Bobwins

Send PM Follow Ignore
Followers 562
Posts 17609
Boards Moderated 42
Alias Born 10/21/2003

Bobwins

Re: None

Monday, 02/26/2018 12:53:12 PM

Monday, February 26, 2018 12:53:12 PM

Post# of 10861
ATE.v/ATBPF C$.29

Interesting little Canadian biotech. They have results coming out on their lead drug, ATB-346 in March. ATB-346 is a variation on Naproxen for pain relief. They have altered the formula to reduce stomach problems and high blood pressure effects from the naproxen. Pain relief is a huge category and chronic pain patients who have to take high dosage NSAID's for pain relief would welcome a product without serious side effects.

http://www.antibethera.com/wordpress/pdf/presentations/Antibe%20Investor%20Presentation%20-%20January%202018.pdf

Please post stock symbols first in all your posts. If it's a foreign stock, please list the US pk equivalent symbol.

If the Commodities Boom is Over, I am just a Gold Bug headed for the Windshield of LIFE

Public Reply Private Reply New Post
Keep Last Read
Replies (2) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (2) Next 10 Prev Next

Unleash the power of Level 2

Spot liquidity moves with access to US order books.

Sign Up